Tenecteplase has risks but cuts hemodynamic decompensation in pulmonary embolism

Fibrinolytic therapy with tenecteplase prevents hemodynamic decompensation in patients with intermediate-risk pulmonary embolism but raises the risk of major hemorrhage and stroke, so its use is...